http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0599692-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f5037f9201419291d55caa0f3e78dee
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N33-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N35-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N33-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N33-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N37-02
filingDate 1993-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d66214e40c094d14cce54e67b7584c71
publicationDate 1994-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0599692-A1
titleOfInvention Use of a pyrrolydone derivative for enhancing the bactericidal activity of a bactericidal agent
abstract The invention relates to the use of a pyrrolidone derivative for potentiating the bactericidal activity of a bactericidal agent.n n n The pyrrolidone derivative may be 2-pyrrolidone or a polyvinylpyrrolidone and be used in an amount between 0.001% and 5% by weight relative to the total weight of the bactericidal composition in its final form for bactericidal use.n n n The potentiating effect of the pyrrolidone derivative is particularly unexpected.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008074038-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2007333054-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010143428-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008074038-A3
priorityDate 1992-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0252310-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0361033-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0212866-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72392
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1772
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22074305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233969619
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233969617
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226498860
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1772
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413262
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19374075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136111159
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88303471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234825157
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2337

Total number of triples: 39.